Search Results

Strategic combinations to overcome therapeutic resistance and relapse in acute myeloid leukemia

Acute myeloid leukemia (AML) is the most fatal type of leukemia and has a high rate of relapse following current therapies. We have recently uncovered…

A phase 1b/2 study targeting apoptotic and signaling pathways in T-acute lymphoblastic leukemia

lymphoblastic leukemia () is an aggressive leukemia with limited treatment options after chemotherapy. Our preclinical work in animal models of demo…

Stem cell features and Notch signaling in p53 deleted multiple myeloma

We have investigated the consequences of p53 loss on stem cell properties, namely clonogenic growth, , and drug resistance in multiple myeloma. We hav…

Defining mechanisms of sensitivity and resistance to PI3K gamma inhibition in AML

The goal of our laboratory is to discover, study, and the translate new leukemia therapies to the clinic. In this project, we are studying a signaling…

Suggested Reading - Bone Marrow and Blood Stem Cell Transplants: A Guide for Patients

A comprehensive and book that's a must for patients considering a transplant using donor bone marrow, blood stem cells or cord blood. The book walks …

LLS Community Guide: Joining groups to see disease and topic specific content​

Kiadis announces new data at the 2020 ASH Annual Meeting and Exposition

Amsterdam, The Netherlands, December , – Kiadis Pharma N.V. (“Kiadis” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a biopharmaceutical …

Kymera Therapeutics Presents Preclinical Data on IRAKIMiD and STAT3 Programs at ASH

WATERTOWN, Mass., Dec. , - Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company advancing targeted protein degradation to deliver no…

Caregiver Support May Lead To Better Outcomes For Both Patients And Caregivers

It goes without saying that cancer causes a great burden on the patient, but few consider the great burden it causes on the informal caregivers. An i…

The Leukemia & Lymphoma Society, now Blood Cancer United, collaborates with The US Oncology Network to advance care in community cancer centers

WASHINGTON, Nov , — The Leukemia & Lymphoma Society, now Blood Cancer United®, and The US Oncology Network have established a collaboration to connec…

Suggested Reading - 100 Questions & Answers About Caring for Family or Friends with Cancer

For people who are supporting someone through the mental or physical ordeal of a cancer diagnosis, this book is a guide to the challenges and offers …

Suggested Reading - Childhood Cancer Survivors: A Practical Guide to Your Future, 3rd Ed.

The treatments used to cure cancer in children can affect their growing bodies and developing minds. This book provides information on medical late ef…

Improving Blood Cancer Survival Takes More than New Drug Discovery

In my years as a practicing and now as chief medical officer of The Leukemia & Lymphoma Society (LLS), I’ve met many blood cancer patients who worry …

Staying Connected®: Facilitating the Learning Experience During & After Cancer Treatment

Optimizing Clinical Outcomes in Blood Cancers through Groundbreaking Translational Research

Could Humor Help Your Family Cope with a Blood Cancer Diagnosis?

Love, Strength, Support: Sibling care in pediatric blood cancer journeys

Key Insights: Treating Blood Cancer Patients with CAR T-cell Therapy

Blood Cancer United & Wawa Support Patients Where It Matters Most

WASHINGTON, April , — For people undergoing treatment for blood cancer, the hardest moments often happen between appointments: getting home after che…

FDA Approves New Treatment for an Ultra‑Rare, Aggressive Blood Cancer

“This is meaningful for patients with BPDCN, where choices have historically been limited, especially for those whose disease has relapsed or stopped …

Blood Cancer United Condemns Congressional Inaction on Healthcare Tax Credits

WASHINGTON, Dec. , —Today marks the culmination of Congress’s failure to extend enhanced premium tax credits (APTCs). House leadership refused to allo…

‘SKINNY’ SENATE HEALTHCARE BILL WOULD THREATEN ACCESS TO CANCER TREATMENT

Rye Brook, N.Y. (July , ) – The U.S. Senate has initiated debate on the healthcare bill, and Senate leaders are indicating they intend to advance leg…

Survey Reveals Striking Lack of Knowledge of Major Cancer Killer

View full multimedia release here. Rye Brook, NY (August , ) – Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Am…

We Are Turning It Red for Blood Cancer Awareness Month

Coming to a city near you starting Sept 1st! We are lighting it red for YOU as a symbol of our support and in honor of Blood Cancer Awareness Month. …

LLS Fuels Next Generation of Cancer Research Committing $188 Million

View full multimedia release here.